1-3 of 3
Hollie Devine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)

William Blum, MD, Rebecca Klisovic, MD, Shujun Liu, PhD, Ramiro Garzon, MD, Cheryl Kefauver, RN, Zhongfa Liu, PhD, Jon Mickle, CNP, Hollie Devine, CNP, Steve Devine, MD, Michael R Grever, MD, Kenneth K Chan, PhD, Miguel Villalona-Calero, MD, John C. Byrd, MD, Guido Marcucci, MD
Journal: Blood
Blood (2008) 112 (11): 2957.
https://doi.org/10.1182/blood.V112.11.2957.2957
Published: 2008
Journal Articles

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Clinical Trials & Observations
Steven M. Devine, Ravi Vij, Michael Rettig, Laura Todt, Kiley McGlauchlen, Nicholas Fisher, Hollie Devine, Daniel C. Link, Gary Calandra, Gary Bridger, Peter Westervelt, John F. DiPersio
Journal: Blood
Blood (2008) 112 (4): 990–998.
https://doi.org/10.1182/blood-2007-12-130179
Published: 2008
Journal Articles

Imatinib Mesylate-Induced Complete Cytogenetic Response in Acute Myeloid Leukemia with t(5;12)(q33;p13).

William Blum, MD, Guido Marcucci, MD, Hollie Devine, CNP, Rebecca Klisovic, MD
Journal: Blood
Blood (2006) 108 (11): 4414.
https://doi.org/10.1182/blood.V108.11.4414.4414
Published: 2006